Autologous Vs. Allogenic
Cell therapy products are manufactured from either an origin of autologous or allogeneic cells or tissue. Autologous cell therapy products are manufactured from the patient’s own cells or tissue, while allogeneic cell therapy products are derived from a donor other than the patient. Autologous cell therapy products have been in clinical use for over 30 years using cellular material from bone marrow, white blood cells, and platelets. In the recent decade, a strong push has been made to develop autologous cell therapy derived from adipose derived stem cells.
Where autologous cell therapy is personalized, allogeneic cell therapy is not and the manufacturing process differs in that it often involves extensive cell processing.
Copyright © 2020 PrimeGen Global
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images and information, contained on or available through this web site is for general information purposes only. VetCell Therapeutics USA makes no representation and assumes no responsibility for the accuracy of information contained on or available through this web site, and such information is subject to change without notice.
You are encouraged to confirm any information obtained from or through this web site with other sources, and review all information regarding any medical condition or treatment with your physician.
NEVER DISREGARD PROFESSIONAL MEDICAL ADVICE OR DELAY SEEKING MEDICAL TREATMENT BECAUSE OF SOMETHING YOU HAVE READ ON OR ACCESSED THROUGH ANY WEB SITE.